Health condition · Clinically reviewed
Hyperglycaemia, from a single high reading to a modern diabetes plan.
High blood glucose is common, treatable and - with the right ladder - usually controllable. Modern UK care goes well beyond metformin and insulin.
Why trust this guide
- 01
Clinically reviewed
Written by our editorial team and reviewed by a registered UK clinician before publication.
- 02
Sourced from guidance
Checked against NICE, ADA and IDF sources you can see at the end.
- 03
Current for 2026
Reflects modern UK diabetes care including SGLT2 inhibitors, GLP-1 agonists, tirzepatide and hybrid closed-loop insulin systems.
Key facts
Hyperglycaemia at a glance.
The essentials, in plain English - what it is, the common triggers, and how it is treated in the UK today.
-
What it is
Elevated blood glucose - fasting above 7.0 mmol/L, random or two-hour OGTT above 11.1 mmol/L, or HbA1c of 48 mmol/mol (6.5%) or higher.
-
Main cause
Diabetes - most often type 2, sometimes type 1, LADA, MODY, gestational or a secondary form driven by another illness.
-
Common triggers
Steroids, antipsychotics, thiazides, critical illness and pancreatic disease can all push glucose up quickly.
-
Warning symptoms
Thirst, frequent urination, weight loss, fatigue, blurred vision and slow wound healing all suggest sustained hyperglycaemia.
-
Emergencies
DKA in type 1 and hyperosmolar hyperglycaemic state (HHS) in type 2 are medical emergencies needing hospital care.
-
Modern treatment
A stepped ladder from lifestyle and metformin to SGLT2 inhibitors, GLP-1 agonists, tirzepatide and, when needed, insulin.
Why this guide matters
A stepped plan, not a shelf of pills.
Diabetes care has changed. The three points below reshape what a good hyperglycaemia plan looks like in 2026.
-
The ladder is longer than metformin
SGLT2 inhibitors and GLP-1 agonists now sit alongside metformin, with heart and kidney protection in their own right.
-
Weight is a therapeutic target
Tirzepatide, semaglutide and bariatric surgery can drive weight loss large enough to push type 2 diabetes into remission.
-
Technology has arrived in type 1
Hybrid closed-loop systems combine pump and CGM to adjust insulin minute by minute - transforming glucose stability.
How the diagnosis is made
From first symptoms to a clear plan.
The steps a UK GP or diabetes team will normally follow - so you know what to expect and why each test is being done.
Phase 1 · Assessing
Risk, symptoms and examination
Phase 2 · Confirming
Blood tests and severity
Phase 3 · Typing
Antibodies, C-peptide and MDT
- 01
Assessing
History and risk factors
Family history, medications, weight, activity and ethnicity all shape diabetes risk and the likely cause of high glucose.
- 02
Assessing
Symptom review
Polyuria, polydipsia, weight loss, blurred vision and recurrent infections point to sustained hyperglycaemia.
- 03
Assessing
Focused examination
Weight, blood pressure, hydration, Kussmaul breathing, ketotic breath and skin changes such as acanthosis nigricans.
- 04
Confirming
Blood glucose and HbA1c
Fasting glucose, random glucose and a confirmatory HbA1c at our HbA1c clinic set the diagnosis and severity.
- 05
Confirming
Urgent bloods if unwell
U&Es, venous gas, ketones, ABG and urinalysis if DKA or HHS is suspected - a same-day hospital assessment.
- 06
Typing
Antibodies and C-peptide
GAD, IA-2, ZnT8 and insulin antibodies plus C-peptide help separate type 1, LADA and type 2 when the picture is mixed.
- 07
Typing
Specialist and MDT input
Genetic testing for MODY, endocrine review for Cushing or acromegaly, and diabetes team referral where care needs to be shared.
Typical timeline: a first visit to a settled plan in weeks, not months.
Symptoms
What hyperglycaemia feels like.
The classic mix of thirst, urination and fatigue - plus the features that mean it is time to seek same-day care.
-
Polyuria and polydipsia
Passing large volumes of urine and drinking constantly - the classic pair when glucose spills into the urine.
-
Unintended weight loss
Loss of muscle and fat despite eating - a hallmark of insulin deficiency, especially in type 1.
-
Fatigue and low energy
Persistent tiredness that improves once glucose is brought back under control.
-
Blurred vision
Osmotic changes in the lens - usually reversible once glucose stabilises over a few weeks.
-
Recurrent infections
Thrush, urinary tract infections and slow-healing skin infections point to poorly controlled glucose.
-
Acanthosis nigricans
Velvety darkening in the neck, armpits or groin - a marker of insulin resistance.
-
Poor wound healing
Cuts, ulcers and surgical wounds heal slowly - a reason for early assessment, especially of the feet.
-
Red flag - DKA or HHS
Vomiting, deep sighing breathing, drowsiness or confusion with high glucose - a medical emergency.
Treatment
How hyperglycaemia is treated in the UK.
Lifestyle and metformin first, then SGLT2 inhibitors, GLP-1 agonists and tirzepatide, with insulin and pump technology reserved for those who need them.
-
Lifestyle foundations
A Mediterranean or lower-carbohydrate pattern, weight loss, regular activity, stopping smoking and moderating alcohol - the base of every plan.
-
Metformin
First-line oral therapy in type 2 - improves insulin sensitivity, is inexpensive and has decades of safety data.
-
SGLT2 inhibitors
Dapagliflozin, empagliflozin and canagliflozin lower glucose while protecting heart and kidneys - reviewed at our SGLT2 inhibitor clinic.
-
GLP-1 agonists
Semaglutide (Ozempic, Rybelsus, Wegovy), liraglutide and dulaglutide - powerful glucose and weight benefits with cardiovascular protection.
-
Tirzepatide (Mounjaro)
Dual GIP/GLP-1 agonist - the strongest weight-loss data in type 2, prescribed via our tirzepatide obesity clinic.
-
DPP-4 inhibitors
Sitagliptin and linagliptin - weight-neutral oral options often added to metformin when other classes are unsuitable.
-
Sulfonylureas and pioglitazone
Gliclazide and pioglitazone remain useful in specific patients where cost, kidney function or intolerance limit newer classes.
-
Insulin therapy
Basal-bolus regimens, pump therapy and hybrid closed-loop systems for type 1 - and for type 2 where oral and injectable options are no longer enough.
What this guide is based on
The sources behind every claim on this page.
UK national guidance and international specialist society standards, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not medical advice.
Your GP or diabetes team knows your history and can tell you which parts apply to you. If you are unwell with high glucose, seek same-day care.
-
NICE. Type 2 diabetes in adults: management (NG28).
-
NICE. Type 1 diabetes in adults: diagnosis and management (NG17).
-
American Diabetes Association (ADA). Standards of Care in Diabetes.
-
International Diabetes Federation (IDF). Global guideline for type 2 diabetes.
-
Diabetes UK. Information and support for people living with diabetes.
Red flags
When high glucose needs urgent attention.
Most hyperglycaemia is managed in primary care with the diabetes team. These are the situations that are not - and where hospital review is needed.
-
Diabetic ketoacidosis (DKA)
Vomiting, deep sighing breathing, abdominal pain and drowsiness with high glucose - especially in type 1. A hospital emergency.
-
Hyperosmolar hyperglycaemic state
Very high glucose, severe dehydration and confusion in type 2 - usually in older adults. Needs urgent hospital care.
-
New severe symptoms in a child
Rapid thirst, weight loss and tiredness in a child or young adult - assume new type 1 diabetes and seek same-day review.
-
Persistent glucose above 20 mmol/L
Very high readings, ketones on the meter or a rising illness - contact the diabetes team or urgent care.
-
Sick-day pattern
Infection, vomiting or steroids can push glucose up quickly - a documented sick-day plan is essential for anyone on insulin.
-
Pregnancy with high glucose
New or worsening hyperglycaemia in pregnancy needs same-week specialist review to protect mother and baby.
-
Foot ulcer or infection
Any new ulcer, redness or wound on the foot in someone with diabetes deserves urgent podiatry or diabetes team review.
-
Post-transplant hyperglycaemia
New high glucose after solid-organ transplant is common with immunosuppression and needs specialist input.
-
Endocrine features
Cushingoid changes, acromegalic features or paroxysmal hypertension - consider Cushing, acromegaly or phaeochromocytoma.
Living with it
A treatable condition, with a clear ladder.
Four things that make the biggest difference day to day - steady routines, honest monitoring, a written sick-day plan and the courage to escalate.
A quiet reminder
Time in range beats a single perfect reading.
A modestly higher time-in-range every week, kept up for months, protects heart, eyes, kidneys and nerves more than any short-lived spell of perfect numbers.
- 01 Routine
Build steady habits
Regular meals, daily activity and consistent medication timing keep glucose in a narrower range than any single big change.
- 02 Monitor
Know your numbers
HbA1c every three to six months, and CGM or flash monitoring where indicated - trends matter more than any single reading.
- 03 Sick days
Plan for illness
A written sick-day plan, ketone strips for type 1 and clear escalation numbers protect you when infection or steroids strike.
- 04 Escalate
Ask for more, sooner
If HbA1c is not moving, the ladder from metformin to SGLT2, GLP-1 or insulin exists for a reason - a specialist review is a right, not a favour.
Frequently asked
Everything we get asked about hyperglycaemia.
Quick answers on diagnosis thresholds, drug classes, remission and the newer technology in type 1 care.
-
What counts as hyperglycaemia?
Fasting blood glucose above 7.0 mmol/L, a random or two-hour OGTT value above 11.1 mmol/L, or an HbA1c of 48 mmol/mol (6.5%) or higher. Any of these on two occasions confirms diabetes; a single reading with classic symptoms is enough on its own.
-
What causes high blood glucose apart from diabetes?
Stress or critical illness, medications such as steroids, antipsychotics, thiazides and some beta-blockers, pancreatic disease including chronic pancreatitis and pancreatic cancer, endocrine conditions such as Cushing syndrome or acromegaly, and post-transplant immunosuppression can all raise glucose.
-
What are DKA and HHS?
Diabetic ketoacidosis is a life-threatening complication of type 1 diabetes with high glucose, ketones and acidosis. Hyperosmolar hyperglycaemic state is the type 2 equivalent, with very high glucose and severe dehydration. Both need urgent hospital care with fluids, insulin and careful potassium replacement.
-
How is type 2 diabetes treated in 2026?
Lifestyle change and metformin remain the foundation. SGLT2 inhibitors and GLP-1 agonists such as semaglutide, and tirzepatide, are now used early because they protect the heart and kidneys and reduce weight. Insulin is added when oral and injectable options are no longer enough.
-
Can type 2 diabetes go into remission?
Yes - substantial weight loss through diet, medication or bariatric surgery can bring HbA1c below the diabetes threshold in a meaningful share of people, especially within the first five to ten years of diagnosis. Monitoring continues even in remission.
-
What is a hybrid closed-loop system?
A pump and continuous glucose monitor that talk to each other, adjusting insulin every few minutes based on real-time glucose. NHS commissioning has expanded access for type 1 diabetes, and our hybrid closed-loop clinic supports set-up and follow-up.
Related content
Keep reading.
-
Type 1 diabetes
Autoimmune insulin deficiency in adults and children.
Learn more -
Type 2 diabetes
The most common cause of sustained hyperglycaemia.
Learn more -
Hypoglycaemia
The other side of glucose control - low blood sugar.
Learn more -
Hyperkalaemia
Related electrolyte disturbance in DKA and HHS.
Learn more -
GLP-1 weight-loss clinic
Semaglutide and liraglutide for weight and glucose.
Learn more -
SGLT2 inhibitor clinic
Heart and kidney protection alongside glucose control.
Learn more -
Tirzepatide obesity clinic
Dual GIP/GLP-1 therapy for weight and type 2 diabetes.
Learn more -
HbA1c clinic
The main blood test used to diagnose and monitor.
Learn more